Inferra AI / Company / CERT

Certara, Inc.

CERT · Health Care

No earnings release for Certara, Inc. is held in this edition of the library, so no earnings line is shown.

Key results

Revenuequarter

$93.3 million

Revenue was $93.3 million, compared to $92.4 million in the second quarter of 2025, representing growth of 1%.

SEC original ↗Certara, Inc. — Earnings release (8-K exhibit)EX-99Aug 4, 2026

Software revenuequarter

$48.8 million

Software revenue was $48.8 million , compared to $46.7 million in the second quarter of 2025, representing growth of 4%.

SEC original ↗Certara, Inc. — Earnings release (8-K exhibit)EX-99Aug 4, 2026

Services revenuequarter

$44.5 million

Services revenue was $44.5 million, compared to $45.7 million in the second quarter of 2025, representing a decrease of 3%.

SEC original ↗Certara, Inc. — Earnings release (8-K exhibit)EX-99Aug 4, 2026

Total revenuequarter

$93.3 million

Total revenue for the second quarter of 2026 was $93.3 million, representing year-over-year growth of 1% on a reported basis.

SEC original ↗Certara, Inc. — Earnings release (8-K exhibit)EX-99Aug 4, 2026

Software revenue for the second quarter of 2026 was $48.8 million, representing year-over-year growth of 4% on a reported basis.

SEC original ↗Certara, Inc. — Earnings release (8-K exhibit)EX-99Aug 4, 2026

Services revenue for the second quarter of 2026 was $44.5 million, representing a year-over-year decrease of 3% on a reported basis.

SEC original ↗Certara, Inc. — Earnings release (8-K exhibit)EX-99Aug 4, 2026

Total cost of revenues for the second quarter of 2026 was $35.1 million, an increase of $0.8 million from $34.3 million in the second quarter of 2025.

SEC original ↗Certara, Inc. — Earnings release (8-K exhibit)EX-99Aug 4, 2026

The increase in cost of revenues was primarily due to a $1.0 million increase in employee-related costs and a $0.9 million increase in professional and consulting expenses, partially offset by a decrease in equity-based compensation expense and other miscellaneous expenses.

SEC original ↗Certara, Inc. — Earnings release (8-K exhibit)EX-99Aug 4, 2026

AI analysis

Q2 2026 · reported Aug 4, 2026

Based on: Earnings release + parent 8-K + 10-Q — transcript not held

Revenue · Q2 2026

$93.3M

+1.0% +$900.00K vs year ago computed from stated figures

EX-99 · Aug 4, 2026

Software revenue · Q2 2026

$48.8M

+4.5% vs year ago computed from stated figures

EX-99 · Aug 4, 2026

Services revenue · Q2 2026

$44.5M

-2.6% vs year ago computed from stated figures

EX-99 · Aug 4, 2026

Total revenue · Q2 2026

$93.3M

EX-99 · Aug 4, 2026

The quarter in charts

Revenue — quarterly

As stated

EX-99 · Aug 4, 2026 Statement values as stated in the release.

Guidance ladder — revenue

Delivered vs the company's guided range

Q2 2026 delivered$93.3M

Guided range (company-stated)$0.1B · midpoint $0.1B

0$B

EX-99 · Aug 4, 2026 Guide as stated by the company; range and midpoint computed from the stated figure.

Segment mix

Business-unit revenue, as stated

Segment revenue figures as stated in the event record.

Headline figures

Metric	Q2 2026	Prior qtr	Year ago
Revenue	$93.3 million	—	$92.4 million
Software revenue	$48.8 million	—	$46.7 million
Services revenue	$44.5 million	—	$45.7 million
Total revenue	$93.3 million	—	—

EX-99 · Aug 4, 2026

Guidance · company-stated

Direction: Reiterated

Revenue$100 million

“1 Certara Reports Second Quarter 2026 Financial Results A ppoints Julien Perrier Chief Commercial Officer Completes previously authorized $100 million share repurchase program Board authorizes additional $50 million under repurchase program Reaffirms 2026 revenue guidance RADNOR, PA August 4, 2026 -- Certara, Inc.”

Revenue

“3 4 2026 Financial Outlook Certara is reaffirming its revenue growth and updating its adjusted EBITDA margin, adjusted diluted earnings per share, and fully diluted share guidance for the full year 2026, to reflect the divestiture of the Regulatory and Medical Writing business and Continuing Operations reporting Revenue growth for Continuing Operations, excluding the Regulatory and Medical Writing business, is expected to be 0% to 4%, or revenue of $367 million to $382 million.”

Midpoint vs latest-quarter revenue+7.2%computed from stated figures

Classified from the release's primary full-year outlook statement.

Next earningsNo verified date on fileNo date is estimated or imported

Capital allocation

Revenue$100M

Revenue$50M

htm EX-99 Document Exhibit 99.1 Certara Reports Second Quarter 2026 Financial Results A ppoints Julien Perrier Chief Commercial Officer Completes previously authorized $100 million share repurchase program Board authorizes additional $50 million under repurchase program Reaffirms 2026 revenue guidance RADNOR, PA August 4, 2026 -- Certara, Inc.

What changed vs last quarter

Guide midpoint vs latest-quarter revenue +7.2% computed from stated figures

General educational research only — not investment advice.Every figure is as stated in the held documents; values marked “computed from stated figures” are arithmetic on those stated figures. Guidance shown is the company’s own stated guidance. No price targets, no recommendations, no consensus estimates.

Event summary

Second Quarter Highlights from Continuing Operations Financial results of the Regulatory and Medical Writing business are reported as discontinued operations

Based on: Earnings release + parent 8-K + 10-Q — transcript not held

Guidance & outlook

Direction: Reiterated

Revenue: “1 Certara Reports Second Quarter 2026 Financial Results A ppoints Julien Perrier Chief Commercial Officer Completes previously authorized $100 million share repurchase program Board authorizes additional $50 million under repurchase program Reaffirms 2026 revenue guidance RADNOR, PA August 4, 2026 -- Certara, Inc.”

Revenue: “3 4 2026 Financial Outlook Certara is reaffirming its revenue growth and updating its adjusted EBITDA margin, adjusted diluted earnings per share, and fully diluted share guidance for the full year 2026, to reflect the divestiture of the Regulatory and Medical Writing business and Continuing Operations reporting Revenue growth for Continuing Operations, excluding the Regulatory and Medical Writing business, is expected to be 0% to 4%, or revenue of $367 million to $382 million.”

Revenue — Reiterated (“Reaffirms”)
“1 Certara Reports Second Quarter 2026 Financial Results A ppoints Julien Perrier Chief Commercial Officer Completes previously authorized $100 million share repurchase program Board authorizes additional $50 million under repurchase program Reaffirms 2026 revenue guidance RADNOR, PA August 4, 2026 -- Certara, Inc.”

Revenue — Reiterated (“reaffirming”)
“3 4 2026 Financial Outlook Certara is reaffirming its revenue growth and updating its adjusted EBITDA margin, adjusted diluted earnings per share, and fully diluted share guidance for the full year 2026, to reflect the divestiture of the Regulatory and Medical Writing business and Continuing Operations reporting Revenue growth for Continuing Operations, excluding the Regulatory and Medical Writing business, is expected to be 0% to 4%, or revenue of $367 million to $382 million.”

Classified from the release's primary full-year outlook statement.

Capital allocation

SEC original ↗Certara, Inc. — Earnings release (8-K exhibit)EX-99Aug 4, 2026

In the second quarter, the Company repurchased $17.4 million in shares, which completed a $100 million share repurchase program under terms previously authorized by the Board.

SEC original ↗Certara, Inc. — Earnings release (8-K exhibit)EX-99Aug 4, 2026

In the third quarter, the Board approved an additional $50 million under the share repurchase program, reflecting the Company s continued confidence in the business and its disciplined approach to capital allocation.

SEC original ↗Certara, Inc. — Earnings release (8-K exhibit)EX-99Aug 4, 2026

The program does not have an express expiration date, and all repurchase plans must be brought in advance to the Board.

SEC original ↗Certara, Inc. — Earnings release (8-K exhibit)EX-99Aug 4, 2026

The ASU enables entities to apply hedge accounting to a greater number of highly effective economic hedges in the following five areas: similar risk assessment for cash flow hedges, hedging forecasted interest payments on choose-your-rate debt instruments, cash flow hedges of nonfinancial forecasted transactions, net written options as hedging instruments, and foreign-currency-denominated debt instrument as hedging instrument and hedged item(dual hedge).

SEC original ↗Certara, Inc. — 10-Q Quarterly report10-QAug 4, 2026

The Company may enter into derivative contracts such as interest rate swap contracts that effectively convert portions of the Company s floating rate debt to a fixed rate, which serves to mitigate interest rate risk.

SEC original ↗Certara, Inc. — 10-Q Quarterly report10-QAug 4, 2026

Strategy & priorities

Our second quarter results were in line with our expectations, and we remain focused on executing against our full-year plan, said Faiz Mohammed, Interim Chief Financial Officer.

SEC original ↗Certara, Inc. — Earnings release (8-K exhibit)EX-99Aug 4, 2026

Perrier will focus on deepening customer engagement, sharpening go-to-market execution, and ensuring Certara s products and services deliver clear, demonstrable value to customers worldwide.

SEC original ↗Certara, Inc. — Earnings release (8-K exhibit)EX-99Aug 4, 2026

He joined Certara in 2022 and has helped scale the business globally by partnering with all functions as a strategic business partner.

SEC original ↗Certara, Inc. — Earnings release (8-K exhibit)EX-99Aug 4, 2026

Equity-based compensation has been, and will continue to be for the foreseeable future, a recurring expense in our business and an important part of our compensation strategy.

SEC original ↗Certara, Inc. — Earnings release (8-K exhibit)EX-99Aug 4, 2026

All statements (other than statements of historical facts) in this Quarterly Report regarding the prospects of the industry and our prospects, plans, financial position and business strategy may constitute forward-looking statements.

SEC original ↗Certara, Inc. — 10-Q Quarterly report10-QAug 4, 2026

Risks & headwinds

Any statement in this press release that is not a statement of historical fact is a forward-looking statement and involves significant risks and uncertainties.

SEC original ↗Certara, Inc. — Earnings release (8-K exhibit)EX-99Aug 4, 2026

Such statements reflect the current views of our management with respect to our operations, results of operations and future financial performance and are subject to various risks and uncertainties.

SEC original ↗Certara, Inc. — 10-Q Quarterly report10-QAug 4, 2026

Operational disruptions, funding constraints and policy changes at the FDA and other government agencies could adversely affect regulatory activity and our business.

SEC original ↗Certara, Inc. — 10-Q Quarterly report10-QAug 4, 2026

Issues relating to the implementation, use and development of artificial intelligence ( AI ) and machine learning in our products and services may result in reputational harm, regulatory action, or legal liability, 3 Table of Contents and any failure to adapt to such technological developments or industry trends could adversely affect the competitiveness of our business.

SEC original ↗Certara, Inc. — 10-Q Quarterly report10-QAug 4, 2026

We regularly evaluate potential acquisitions and other strategic transactions that we deem beneficial and strategic to our long-term growth and profitability, which could divert our management s attention, result in additional dilution to our stockholders, and otherwise disrupt our operations and adversely affect our operating results.

SEC original ↗Certara, Inc. — 10-Q Quarterly report10-QAug 4, 2026

Our estimated addressable market is subject to inherent challenges and uncertainties.

SEC original ↗Certara, Inc. — 10-Q Quarterly report10-QAug 4, 2026

Documents

Earnings deck slides

0 decks with slide view

Certara, Inc. — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.

Competitors